The past decade in advanced breast cancer (ABC) care has gone under the microscope, with a new study revealing dramatic advances in survival outcomes, while cautioning that life-extending drugs reach just 51% of low-middle income countries…
The past decade in advanced breast cancer (ABC) care has gone under the microscope, with a new study revealing dramatic advances in survival outcomes, while cautioning that life-extending drugs reach just 51% of low-middle income countries…